Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1764

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 7A
Chunk 1764
---
  
    $119,542 

Future
minimum lease liability payments under non-cancelable operating lease at December 31, 2024 and 2023 are as follows:

Schedule
of Future Minimum Lease Liability Payments Under Non-cancelable Operating Lease

    2024 
     -  
     49,004 
  
    2025 
     50,476  
     50,476 
  
    2026 
     21,290  
     21,290 
  
    Total lease payments 
     71,766  
     120,770 
  
    Less: imputed interest 
     (437) 
     (1,228)
  
    Total lease liabilities 
    $71,329  
    $119,542 

    Current operating lease liabilities 
     50,082  
     48,213 
  
    Non-current operating lease liabilities 
     21,247  
     71,329 
  
    Total lease liabilities 
    $71,329  
    $119,542 

    F-23

JUPITER
NEUROSCIENCES, INC.

NOTES
TO FINANCIAL STATEMENTS

December
31, 2024 and 2023

Note
8 – Commitments and Contingencies, continued

Office
Lease, continued

On
October 1, 2021, the Company entered into a month-to-month lease for office space in Charlestown, MA.

Rental
expenses of $17,740 and $20,844 for the years ended December 31, 2024 and 2023, respectively, are included in general and administrative
expenses on the accompanying statement of operations.

Consulting
Agreements

The
Company utilizes various consultants and advisors for clinical research, scientific advisory services and business strategies. Each consultant
has an executed agreement in place defining term, compensation, duties, confidentiality, intellectual property. The majority of the agreements
have a 2-year term. Agreements are evaluated for renewal upon expiration. Bonus provisions are at the discretion of the Company’s
Board of Directors and are granted on an individual agreement basis.

On
December 15, 2024, the Company entered into a Strategic Services Agreement (the “Dominant Treasure Agreement”) with
Dominant Treasure Health Company Limited (“Dominant Treasure”). Pursuant to the terms of the Dominant Treasure
Agreement, Dominant Treasure agreed to provide certain